Cargando…
Aspirin-exacerbated respiratory disease: Update on medical management
Aspirin-exacerbated respiratory disease (AERD) is frequently diagnosed in patients with severe type 2 airway inflammation presenting with nasal polyps and severe asthma. It has been associated with a recalcitrant course with high medical and surgical requirements. The advent of recent biological and...
Autores principales: | White, Andrew A., Woessner, Katharine, Simon, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729248/ https://www.ncbi.nlm.nih.gov/pubmed/33336180 http://dx.doi.org/10.1016/j.wjorl.2020.07.009 |
Ejemplares similares
-
Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016) -
Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009) -
Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
por: Li, Kevin L., et al.
Publicado: (2019) -
Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
por: Lee, Rachel U., et al.
Publicado: (2011) -
Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)